Cell-free synthetic biology platform that repurposes natural microbial sensors to detect contaminants such as heavy metals, pharmaceuticals, pesticides, and disinfection byproducts. Outputs include fluorescent, colorimetric, or electronic signals, enabling low-cost, sensitive, and field-deployable testing for environmental and health applications.
This platform leverages cell-free synthetic biology to transform natural microbial sensing machinery into practical, low-cost tools for detecting molecular contaminants. Microbial sensors have evolved to recognize a wide range of targets, including heavy metals, pharmaceuticals, small molecules, and pesticides. By rewiring these biological components to control reporter gene expression, the platform produces fluorescence, color, or electrical signals in response to specific analytes. The result is a flexible detection technology that can be deployed outside of traditional laboratory settings, making it well suited for environmental monitoring, water safety, agriculture, biomanufacturing, and human health diagnostics.
The core cell-free biosensing platform has been validated across multiple contaminant classes and has demonstrated functionality in real-world samples. Paper-based, cell-free tests such as the lead-in-water assay have been deployed as field-ready products. Current development efforts focus on extending the platform to chloramine detection through a two-phase plan: first, identifying and characterizing chloramine-responsive sensors using bioinformatics and cell-free testing; second, adapting the sensor into a miniaturized continuous monitoring device with electronic integration. These efforts position the technology at a stage ready for pilot deployment and collaborative refinement toward continuous monitoring applications.
Stemloop, Inc. was a biotechnology company founded in 2019 that specialized in cell-free synthetic biology to create programmable, paper-based biosensors. Developed from academic research at Northwestern University, the company’s platform utilized DNA, RNA, and protein components to detect specific chemical analytes and contaminants in environmental and health contexts. The technology was designed to function without the need for extensive laboratory infrastructure, instead providing rapid, inexpensive, and on-site testing capabilities through simple visual signals, such as color changes, when a target substance was present. The company originated in Evanston, Illinois, and received support from various research programs, including the National Science Foundation and the National Institute of Environmental Health Sciences.
The company focused on democratizing access to testing for critical threats, with a flagship application being the µSense lead-in-water test designed to improve household safety and water quality monitoring. By decentralizing diagnostic capabilities, Stemloop aimed to address challenges that previously required costly and time-consuming analytical chemistry techniques. The company sought to apply its biosensing technology across multiple sectors, including environmental monitoring, agriculture, biomanufacturing, and human health, to deliver actionable information for risk mitigation. Stemloop, Inc. concluded its operations in 2025.